Takeda Pharmaceuticals Korea Co., Ltd.
The Associate Director, Global Labeling Lead drives regulatory labeling strategy for the Plasma-Derived Therapies Business Unit, ensuring successful development and maintenance of labeling for pharmaceutical drugs and devices. This role involves providing strategic insight to internal stakeholders, formulating labeling strategies, and leading cross-functional teams to optimize product potential and patient benefit-risk ratios. The position requires expertise in global labeling requirements and the ability to navigate complex regulatory landscapes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Takeda Pharmaceuticals Korea Co., Ltd..
Global Regulatory Labeling Strategy Lead (Associate Director), Plasma-Derived Therapies Business Unit
BioLife Plasma Services
Global Labeling Lead
Takeda Pharmaceutical Company Limited
Senior Manager, Global Labeling Strategy
Bristol Myers Squibb
Director, Global Regulatory Labeling Strategy
BioLife Plasma Services
Director, Global Regulatory Labeling Strategy
BioLife Plasma Services
Associate Director, Global Regulatory Labeling Strategy
BioLife Plasma Services